What our community says: CAPS All-Stars are solidly backing the stock with 98.2% awarding it an outperform rating. The community at large concurs with the All-Stars with 96.5% granting it a rating of outperform. Fools are keen on Johnson & Johnson and haven't been shy with their opinions lately, logging 3,278 posts in the past 30 days. Johnson & Johnson has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.